UNLOCK 2026 - AI Science: Cutting Through the Hype

​UNLOCK is a one-day summit on April 22, 2026 in San Francisco, focused on how AI is changing drug discovery and life sciences.

​Through keynote talks and expert panels, Unlock creates a forum for substantive discussion about where AI is genuinely advancing biological research and where challenges remain. 

​Speakers include EVPs and SVPs from major pharma companies, founders and builders from the leading AI-bio companies, and researchers from top labs.

• ​Michelle Lee (Founder & CEO, Medra)

• ​Aviv Regev (EVP, Research and Early Development, Genentech)

• ​Jonah Cool (Life Sciences, Anthropic)

• ​Jeremy Elser (Head of Science Operations, Palantir)

• ​Henry Lee (CEO, Cultivarium)

• ​Reshma Shetty (Co-founder & CEO, Ginkgo Bioworks)

• ​Peyton Greenside (Co-founder & CEO, BigHat Biosciences)

• ​Kevin Brown (Founder & CEO, Standard Model Biomedicine)

• ​Ron Alfa (Co-founder & CEO, Noetik)

• ​Alex Morgan (Partner, Khosla Ventures)

• ​Martin Jensen (Co-founder & CSO, Gordian Biotechnology)

• ​Anna Marie Wagner (Co-founder & CEO, Transfyr)

• ​Jacob Kimmel (Co-founder & President, NewLimit)

• ​Sarah Nam (VP, AI Strategy and Partnerships, AbbVie)

• ​Archa Jain (Head of Life Sciences, Goodfire)

​Join us to explore what’s next and help shape it.